NIPH Clinical Trials Search

Basic Information

Recruitment status	completed
Health condition(s) or Problem(s) studied
Date of first enrollment	11/02/2016
Target sample size	300
Countries of recruitment	North America,Japan,Europe,Oceania
Study type	Interventional
Intervention(s)	investigational material(s) Generic name etc : INN of investigational material : Pembrolizumab , Pomalidomide, Dexamethasone Therapeutic category code : 429 Other antitumor agents Dosage and Administration for Investigational material : control material(s) Generic name etc : INN of investigational material : Pomalidomide, Dexamethasone Therapeutic category code : 429 Other antitumor agents Dosage and Administration for Investigational material :

Outcome(s)

Primary Outcome	efficacy efficacy
Secondary Outcome	efficacy

Key inclusion & exclusion criteria

Age minimum	>= 18age old
Age maximum	Not applicable
Gender	Both
Include criteria
Exclude criteria